About Warp Drive Bio
Warp Drive Bio is a company based in Cambridge (United States) founded in 2012 was acquired by Revolution Medicines in October 2018.. Warp Drive Bio has raised $125 million across 1 funding round from investors including Revolution Medicines, Sanofi and Third Rock Ventures. The company has 50 employees as of December 31, 2017. Warp Drive Bio operates in a competitive market with competitors including Jazz Pharmaceuticals, GSK, C4 Therapeutics, DNAnexus and Erasca, among others.
- Headquarter Cambridge, United States
- Employees 50 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Warp Drive Bio, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$125 M (USD)
in 1 rounds
-
Latest Funding Round
$125 M (USD), Series A
Jan 10, 2012
-
Investors
Revolution Medicines
& 3 more
-
Employee Count
50
as on Dec 31, 2017
-
Acquired by
Revolution Medicines
(Oct 16, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
103 people
Senior Team
24 people
Operations Team
21 people
Software Development Team
17 people
Product Management Team
12 people
Data Analysis and Operations Team
12 people
Legal and Compliance
8 people
Sr. Team
7 people
Unlock access to complete
Funding Insights of Warp Drive Bio
Warp Drive Bio has successfully raised a total of $125M through 1 strategic funding round. The most recent funding activity was a Series A round of $125 million completed in January 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $125.0M
-
First Round
First Round
(10 Jan 2012)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2012 | Amount | Series A - Warp Drive Bio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Warp Drive Bio
Warp Drive Bio has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Revolution Medicines, Sanofi and Third Rock Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided to early-stage life science companies.
|
Founded Year | Domain | Location | |
|
Venture capital firm specializing in early-stage tech investments and founder support.
|
Founded Year | Domain | Location | |
|
Pharmaceutical and nutraceutical products are developed across seven therapeutic areas.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Warp Drive Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Warp Drive Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Warp Drive Bio Comparisons
Competitors of Warp Drive Bio
Warp Drive Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, GSK, C4 Therapeutics, DNAnexus and Erasca, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Warp Drive Bio
Frequently Asked Questions about Warp Drive Bio
When was Warp Drive Bio founded?
Warp Drive Bio was founded in 2012.
Where is Warp Drive Bio located?
Warp Drive Bio is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Warp Drive Bio a funded company?
Warp Drive Bio is a funded company, having raised a total of $125M across 1 funding round to date. The company's 1st funding round was a Series A of $125M, raised on Jan 10, 2012.
How many employees does Warp Drive Bio have?
As of Dec 31, 2017, the latest employee count at Warp Drive Bio is 50.
What does Warp Drive Bio do?
Warp Drive Bio was founded in 2012 in Cambridge, United States, within the biotechnology sector. A discovery platform is utilized to identify drugs targeting previously intractable proteins in cancers. Two proprietary technologies are employed: Small Molecule-Assisted Receptor Targeting (SMART) for small molecules against disease-causing proteins, and genome search engines to uncover hidden natural products based on genomic signatures. Initial efforts focus on RAS protein antagonists and natural antibiotics within microbes.
Who are the top competitors of Warp Drive Bio?
Warp Drive Bio's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Who are Warp Drive Bio's investors?
Warp Drive Bio has 4 investors. Key investors include Revolution Medicines, Sanofi, Third Rock Ventures, and Greylock Partners.